Cutaneous Tumor: Clinical Trials

3 trials for Cutaneous Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Recruiting 1, Terminated 1

Follow Cutaneous Tumor: new trials by email Literature Review of Cutaneous Tumor trials Research Report on Cutaneous Tumor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
tolododekin alfa, Cemiplimab - Advanced Solid Tumor, Cutaneous Tumor
Phase 1RecruitingAnkyra Therapeutics, Inc972024-01-192026-03-06
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
JCXH-211 Injection - Cutaneous Tumor, Malignant Solid Tumor
Phase 1CompletedImmorna Biotherapeutics, Inc.192023-02-242026-11-09
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
JCXH-211 - Cutaneous Tumor, Malignant Solid Tumor
Phase 1TerminatedImmorna Biotherapeutics, Inc.12022-10-192026-11-05

Narrower conditions

Skin Neoplasms (3)  ·  Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Neoplasms by Site (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

cemiplimab (1)

Sponsors

Immorna Biotherapeutics, Inc. (2)  ·  Ankyra Therapeutics, Inc (1)

Countries

United States (3)  ·  Canada (1)  ·  China (1)

Top investigators

Joseph Elassal, MD, MBA (1)

Results publications

PMID 41022754